| Towards synthetic viruses G Zuber, E Dauty, M Nothisen, P Belguise, JP Behr Advanced drug delivery reviews 52 (3), 245-253, 2001 | 272 | 2001 |
| Actin cytoskeleton as the principal determinant of size-dependent DNA mobility in cytoplasm: a new barrier for non-viral gene delivery E Dauty, AS Verkman Journal of Biological Chemistry 280 (9), 7823-7828, 2005 | 270 | 2005 |
| Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture E Dauty, JS Remy, T Blessing, JP Behr Journal of the American Chemical Society 123 (38), 9227-9234, 2001 | 240 | 2001 |
| Molecular crowding reduces to a similar extent the diffusion of small solutes and macromolecules: measurement by fluorescence correlation spectroscopy E Dauty, AS Verkman Journal of molecular recognition 17 (5), 441-447, 2004 | 174 | 2004 |
| Intracellular delivery of nanometric DNA particles via the folate receptor E Dauty, JS Remy, G Zuber, JP Behr Bioconjugate chemistry 13 (4), 831-839, 2002 | 160 | 2002 |
| Targeted gene delivery to cancer cells: directed assembly of nanometric DNA particles coated with folic acid G Zuber, L Zammut‐Italiano, E Dauty, JP Behr Angewandte Chemie International Edition 42 (23), 2666-2669, 2003 | 106 | 2003 |
| Quantitative analysis of virus and plasmid trafficking in cells T Lagache, E Dauty, D Holcman Physical Review E 79 (1), 011921, 2009 | 54 | 2009 |
| DNA condensation by an oxidizable cationic detergent. Interactions with lipid vesicles D Lleres, E Dauty, JP Behr, Y Mély, G Duportail Chemistry and Physics of Lipids 111 (1), 59-71, 2001 | 49 | 2001 |
| Investigation of the stability of dimeric cationic surfactant/DNA complexes and their interaction with model membrane systems D Llères, JP Clamme, E Dauty, T Blessing, G Krishnamoorthy, G Duportail, ... Langmuir 18 (26), 10340-10347, 2002 | 47 | 2002 |
| Physical principles and models describing intracellular virus particle dynamics T Lagache, E Dauty, D Holcman Current opinion in microbiology 12 (4), 439-445, 2009 | 35 | 2009 |
| Development of plasmid and oligonucleotide nanometric particles E Dauty, JP Behr, JS Remy Gene therapy 9 (11), 743-748, 2002 | 35 | 2002 |
| Rapid-acting insulin formulation comprising a substituted anionic compound O Soula, G Soula, E Dauty, R Charvet US Patent 9,700,599, 2017 | 18 | 2017 |
| Process for lowering the viscosity of highly concentrated protein solutions E Dauty, T Ballet, R Soula US Patent 9,278,131, 2016 | 11 | 2016 |
| Substituted anionic compounds consisting of a backbone made up of a discrete number of saccharide units G Soula, E Dauty, R Charvet US Patent App. 14/079,437, 2014 | 9 | 2014 |
| Monomolecular condensation of DNA by cationic detergents E Dauty, JP Behr Polymer international 52 (4), 459-464, 2003 | 9 | 2003 |
| Dimerizable detergents as gene transfer vectors T Blessing, E Dauty, JS Remy, JP Behr Journal of Liposome Research 10 (4), 321-327, 2000 | 5 | 2000 |
| Rapid-acting insulin formulation comprising a substituted anionic compound O Soula, G Soula, E Dauty, R Charvet US Patent 10,583,175, 2020 | 3 | 2020 |
| Substituted anionic compounds consisting of a backbone made up of a discrete number of saccharide units G Soula, E Dauty, R Charvet US Patent App. 15/410,524, 2017 | 3 | 2017 |
| Toward a quantitative analysis of virus and plasmid trafficking in cells T Lagache, E Dauty, D Holcman arXiv preprint arXiv:0711.4262, 2007 | 1 | 2007 |
| Compositions in the form of an injectable aqueous solution comprising amylin an amylin receptor agonist or an amylin analog, at least one ionic species and an amphoiphilic … E Dauty US Patent App. 17/263,676, 2021 | | 2021 |
